The purpose of this study is to understand if it is safe and useful to perform SGB (Stellate Ganglion Block) in patients who have severe lung injury Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 infection.
Primary Aim:
• To determine safety of stellate ganglion block (SGB) in ARDS
Secondary Aim:
- To determine efficacy of SGB in slowing the progression of ARDS
Procedure: Stellate Ganglion Block
The procedure will be done at the bedside in the ICU without interfering with ongoing treatment.
Inclusion Criteria:
- Subjects age 18 to 80
- Subjects with PCR documented diagnosis of COVID-19 ARDS requiring critical care and
transfer to intensive care unit
- Bilateral opacities consistent with pulmonary edema must be present and may be
detected on CT or chest radiograph
Exclusion Criteria:
- Subjects with pre-existing cardiac failure
- Hemodynamic Instability
- Subject on Extracorporeal membrane oxygenation (ECMO)
- Anatomical inability to do a stellate block
West Virginia University Rockefeller Neuroscience Institute
Morgantown, West Virginia, United States
Ali R Rezai, MD, Principal Investigator
West Virginia University